DE69811248T2 - Verwendung eines 5ht2 rezeptor-antagonisten zur behandlung von schlafapnoe - Google Patents
Verwendung eines 5ht2 rezeptor-antagonisten zur behandlung von schlafapnoeInfo
- Publication number
- DE69811248T2 DE69811248T2 DE69811248T DE69811248T DE69811248T2 DE 69811248 T2 DE69811248 T2 DE 69811248T2 DE 69811248 T DE69811248 T DE 69811248T DE 69811248 T DE69811248 T DE 69811248T DE 69811248 T2 DE69811248 T2 DE 69811248T2
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- pct
- receptor antagonist
- sleep apnea
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9707998A FR2765107B1 (fr) | 1997-06-26 | 1997-06-26 | Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil |
PCT/FR1998/001100 WO1999000119A1 (fr) | 1997-06-26 | 1998-06-02 | Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69811248D1 DE69811248D1 (de) | 2003-03-13 |
DE69811248T2 true DE69811248T2 (de) | 2003-12-04 |
Family
ID=9508467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69811248T Expired - Lifetime DE69811248T2 (de) | 1997-06-26 | 1998-06-02 | Verwendung eines 5ht2 rezeptor-antagonisten zur behandlung von schlafapnoe |
Country Status (29)
Country | Link |
---|---|
US (1) | US6143792A (de) |
EP (1) | EP1014960B1 (de) |
JP (1) | JP3503953B2 (de) |
KR (1) | KR20010014186A (de) |
CN (1) | CN1154485C (de) |
AT (1) | ATE232094T1 (de) |
AU (1) | AU728227B2 (de) |
BG (1) | BG104038A (de) |
BR (1) | BR9810337A (de) |
CA (1) | CA2295119C (de) |
CZ (1) | CZ291935B6 (de) |
DE (1) | DE69811248T2 (de) |
EE (1) | EE9900595A (de) |
ES (1) | ES2191942T3 (de) |
FR (1) | FR2765107B1 (de) |
HK (1) | HK1028351A1 (de) |
HU (1) | HU229058B1 (de) |
ID (1) | ID23799A (de) |
IL (1) | IL133632A (de) |
IS (1) | IS2356B (de) |
NO (1) | NO325520B1 (de) |
NZ (1) | NZ502495A (de) |
PL (1) | PL190723B1 (de) |
RU (1) | RU2218917C2 (de) |
SK (1) | SK283845B6 (de) |
TR (1) | TR199903197T2 (de) |
TW (1) | TW580386B (de) |
UA (1) | UA59397C2 (de) |
WO (1) | WO1999000119A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
US20060241164A1 (en) * | 1998-02-27 | 2006-10-26 | The Board Of Trustees Of The University Of Illinoi | Pharmacological treatment for sleep apnea |
WO1999043319A1 (en) | 1998-02-27 | 1999-09-02 | The Board Of Trustees Of The University Of Illinois | Agents with serotonin-related activity for the treatment for sleep apnea |
FR2787328A1 (fr) * | 1998-12-22 | 2000-06-23 | Sanofi Sa | Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures |
JP2002538102A (ja) * | 1999-03-01 | 2002-11-12 | セプラコア インコーポレーテッド | 光学的に純粋なr(+)オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法 |
FR2804604B1 (fr) * | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
ES2281666T3 (es) * | 2002-07-19 | 2007-10-01 | Biovitrum Ab | Novedosos derivados de piperazinil-pirazinona para el tratamiento de los desordenes relacionados con el receptor 5-ht2a. |
EP1833467B1 (de) | 2004-12-20 | 2016-08-03 | Collegium Pharmaceutical, Inc. | Pharmazeutische zusammensetzungen gegen schlafstörungen |
EP2266554A1 (de) * | 2009-05-26 | 2010-12-29 | Sanofi-Aventis | Verfahren zur Behandlung von Schlafstörungen mit Eplivanserin |
EP2186511A1 (de) * | 2008-11-13 | 2010-05-19 | Sanofi-Aventis | Verfahren zur Behandlung von Schlafstörungen mittels Epilvanserin |
EP2365805A1 (de) * | 2008-11-13 | 2011-09-21 | Sanofi | Verfahren zur behandlung von schlafstörungen mit eplivanserin |
WO2010079241A1 (es) | 2009-01-12 | 2010-07-15 | Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion | Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas |
EP2255726A1 (de) | 2009-05-26 | 2010-12-01 | Sanofi-Aventis | Spektralprofil für SWS-erweiternde Arzneimittel |
EP2255807A1 (de) | 2009-05-26 | 2010-12-01 | Sanofi-Aventis | Verfahren zur Behandlung von Schlafstörungen mit der Kombination von Eplivanserin und Zolpidem |
EP2269600A1 (de) * | 2009-07-02 | 2011-01-05 | Sanofi-Aventis | Behandlung von Schlafstörungen mit Eplivanserin bei COPD-Patienten |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2639942B1 (fr) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant |
ZA912278B (en) * | 1990-03-29 | 1992-11-25 | Lilly Co Eli | Compounds affecting serotonin receptors |
EP0517984A1 (de) * | 1991-06-11 | 1992-12-16 | Merrell Dow Pharmaceuticals Inc. | Amidanaloge-Derivate von methanoverbrückten Chinolizinen |
-
1997
- 1997-06-26 FR FR9707998A patent/FR2765107B1/fr not_active Expired - Fee Related
-
1998
- 1998-02-06 UA UA99126961A patent/UA59397C2/uk unknown
- 1998-06-02 CN CNB988077329A patent/CN1154485C/zh not_active Expired - Fee Related
- 1998-06-02 IL IL13363298A patent/IL133632A/xx not_active IP Right Cessation
- 1998-06-02 BR BR9810337-7A patent/BR9810337A/pt not_active Application Discontinuation
- 1998-06-02 JP JP50337099A patent/JP3503953B2/ja not_active Expired - Fee Related
- 1998-06-02 EE EEP199900595A patent/EE9900595A/xx unknown
- 1998-06-02 RU RU2000100362/14A patent/RU2218917C2/ru not_active IP Right Cessation
- 1998-06-02 HU HU0002170A patent/HU229058B1/hu not_active IP Right Cessation
- 1998-06-02 CZ CZ19994695A patent/CZ291935B6/cs not_active IP Right Cessation
- 1998-06-02 NZ NZ502495A patent/NZ502495A/xx not_active IP Right Cessation
- 1998-06-02 DE DE69811248T patent/DE69811248T2/de not_active Expired - Lifetime
- 1998-06-02 KR KR19997012261A patent/KR20010014186A/ko not_active Application Discontinuation
- 1998-06-02 ES ES98928407T patent/ES2191942T3/es not_active Expired - Lifetime
- 1998-06-02 US US09/446,484 patent/US6143792A/en not_active Expired - Lifetime
- 1998-06-02 AU AU80243/98A patent/AU728227B2/en not_active Ceased
- 1998-06-02 SK SK1845-99A patent/SK283845B6/sk not_active IP Right Cessation
- 1998-06-02 CA CA002295119A patent/CA2295119C/en not_active Expired - Fee Related
- 1998-06-02 ID IDW991677A patent/ID23799A/id unknown
- 1998-06-02 PL PL98337871A patent/PL190723B1/pl not_active IP Right Cessation
- 1998-06-02 TR TR1999/03197T patent/TR199903197T2/xx unknown
- 1998-06-02 WO PCT/FR1998/001100 patent/WO1999000119A1/fr active IP Right Grant
- 1998-06-02 AT AT98928407T patent/ATE232094T1/de active
- 1998-06-02 EP EP98928407A patent/EP1014960B1/de not_active Expired - Lifetime
- 1998-11-23 TW TW087119387A patent/TW580386B/zh not_active IP Right Cessation
-
1999
- 1999-12-21 IS IS5316A patent/IS2356B/is unknown
- 1999-12-22 BG BG104038A patent/BG104038A/xx unknown
- 1999-12-23 NO NO19996442A patent/NO325520B1/no not_active IP Right Cessation
-
2000
- 2000-12-07 HK HK00107872A patent/HK1028351A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69811248D1 (de) | Verwendung eines 5ht2 rezeptor-antagonisten zur behandlung von schlafapnoe | |
DE69400435T2 (de) | Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen | |
ATE175114T1 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin- vermittelten krankheiten | |
ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
DE60031396D1 (de) | Zubereitung zur behandlung von einer neurologischen erkrankung | |
HK1051005A1 (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
DE69228997T2 (de) | Menschliche il-3-varianten | |
FI973221A0 (fi) | 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina | |
ATE303362T1 (de) | Chalcon-derivate mit antiproliferativer aktivität | |
DE69612510T2 (de) | Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode | |
DE69412073D1 (de) | Xanthinderivate als adenosin-a1 rezeptor antagonisten | |
MXPA02012015A (es) | Ligandos de receptores para integrinas. | |
ATE239458T1 (de) | Verwendung von selegilin zur behandlung von epileptischen erkrankungen | |
ATA57894A (de) | Mittel zur behandlung von osteoporose | |
IL108283A0 (en) | Use of riluzole for promoting restoration following radiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: SANOFI-AVENTIS, PARIS, FR |
|
R082 | Change of representative |
Ref document number: 1014960 Country of ref document: EP Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE |